Genex Pharmaceutical, Inc. engages in the development and production of Reconstituted Bone Xenograft, which is a medical device that accelerates bone healing. The company is headquartered in Tianjin, Tianjin and currently employs 86 full-time employees. The company went IPO on 2006-05-23. The Company’s main business is engaged in producing and distributing Reconstituted Bone Xenograft (RBX). The RBX is used as a medical device that accelerates bone healing. The firm distributes its medical devices to hospitals as well as other medical device customers that are not hospitals. The firm mainly conducts its business in the domestic market.
Follow-Up Questions
What is Genex Pharmaceutical Inc (GENX)'s P/E Ratio?
The P/E ratio of Genex Pharmaceutical Inc is 0.0009
Who is the CEO of Genex Pharmaceutical Inc?
Song Fuzhi is the Chairman of the Board of Genex Pharmaceutical Inc, joining the firm since 2004.
What is the price performance of GENX stock?
The current price of GENX is $0, it has decreased 0% in the last trading day.
What are the primary business themes or industries for Genex Pharmaceutical Inc?
Genex Pharmaceutical Inc belongs to Health Care industry and the sector is Health Care
What is Genex Pharmaceutical Inc market cap?
Genex Pharmaceutical Inc's current market cap is $0
